HZHou-Feng Zheng

Hou-Feng Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hou-Feng Zheng has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Ai-Ling Wang

    Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China

    1 shared publication
  • Bi-Rong Guo

    Department of Dermatology, Department of Emergency, Third Affiliated Hospital of Anhui Medical University and First People's Hospital of Hefei, Hefei, Anhui 230061, China

    1 shared publication
  • Braxton D. Mitchell

    Department of Medicine, University of Maryland School of Medicine, Baltimore, MD

    1 shared publication
  • Celia Margaret T. Greenwood

    Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada

    1 shared publication
  • Claes Ohlsson

    Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    1 shared publication
  • Cong-Sheng Li

    Department of Cardiology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China; Department of Emergency, Third Affiliated Hospital of Anhui Medical University and First People's Hospital of Hefei, Hefei, Anhui 230061, China

    1 shared publication

Latest Publications

  • Open Access

    Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss

    by Jingjing Rong, Houfeng Zheng, Ming Liu, Xu Hu, Tao Wang, Xingwei Zhang, Feng Jin, Li Wang

    Koumiss is a traditionally fermented mare’s milk described with health-promoting potentials for decades. However, only a few studies focused on the probiotic strains isolated from koumiss. In this study, we collected koumiss samples from Inner Mongolian pasturing area of China and selected a promising strain of Lactobacillus helveticus, isolate NS8, based on the survival abilities in gastrointestinal tract (GIT) and adhesion to intestinal endothelial cells in vitro. As the ability to positively modulate host immune response is a feature of increasing importance in measuring the probiotic potential of a bacterial strain, our study mainly focus on the immunomodulatory properties of L. helveticus NS8 by using in vivo and ex vivo analyses. L. helveticus NS8 was identified by molecular-typing methods, both at genus and species levels. As a typical food niche-specific bacteria, NS8 showed a moderate survival ability in GIT environment in vitro. However, an excellent binding capacity to the human intestinal epithelial cells, along with significant autoaggregation and cell-surface hydrophobicity was observed. Additionally, the presence of S-layer protein was responsible for the cell surface properties of this strain. NS8 was found to be rather protective against TNBS (2,4,6-trinitrobenzene sulfonic acid)-induced murine colitis. In the meantime, co-culture with NS8 induced an increased level of secretion of anti-inflammatory cytokine IL-10 in peripheral blood mono-nuclear cells (PBMCs). Furthermore, NS8 was also able to diminish the proinflammatory effects of lipopolysaccharide (LPS) in mouse macrophage cell line RAW264.7 by inducing higher levels of IL-10. Specially, adding of the purified S-layer protein didn’t influence the production of IL-10. The specific ligand-host receptor interactions on the NS8 specific immune responses need to be learned further. In summary, L. helveticus NS8 exhibited good probiotic and particularly immunomodulatory properties, with a potential for development of functional food commercially or therapeutic adjuvant for inflammatory diseases.


  • Association between C-reactive protein gene +1059 G/C polymorphism and the risk of coronary heart disease: a meta-analysis

    by Cong-Sheng Li, Bi-Rong Guo, Zeng Guo, Jing Yang, Hou-Feng Zheng, Ai-Ling Wang

    Background: C-reactive protein (CRP) gene +1059 G/C polymorphism has been reported to be associated with coronary heart disease (CHD) risk, but the results remain inconclusive. This meta-analysis was therefore conducted to clarify these controversies. Methods: A comprehensive search was conducted to identify all case control studies on the association between CRP gene +1059 G/C polymorphism and CHD risk. All the related studies were further strictly selected according to the inclusion criteria. Meta-analysis was performed with STATA 10.1 (StataCorp, USA). The association was assessed by odds ratio (OR) and 95% confidence interval (CI); both Begg's funnel plot and Egger's regression test were used to assess the publication bias. Results: This meta-analysis on a total of 13 studies comprising 6316 CHD cases and 4467 controls showed no significant association between CRP gene +1059 G/C polymorphism and CHD risk in the overall study (for C/C+C/G vs. G/G: OR=1.01, 95% CI=0.81-1.25, P=0.96; for C/C vs. C/G+G/G: OR=1.17, 95% CI=0.77-1.77, P=0.47; for C/C vs. G/G: OR=1.17, 95% CI=0.77-1.77, P=0.47; for C allele vs. G allele: OR=1.01, 95% CI=0.81-1.24, P=0.96). However, in the subgroup analysis by ethnicity, the results showed significant association between CRP gene +1059 G/C polymorphism and CHD risk among Caucasians (for C/C vs. G/G: OR=2.54, 95% CI=1.13-5.72, P=0.02; C/C vs. C/G+G/G: OR=2.45, 95% CI=1.09-5.51, P=0.03), but not among Asians and Africans (P >0.05). Conclusion: CRP gene +1059 G/C polymorphism may be associated with increased CHD risk among Caucasians and more evidences need to validate the conclusion.


  • Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis

    by Fang-Fang Shen, Fu-You Zhou, Qi-Si Xue, Ying Pan, Lu Zheng, Hua Zhang, Li-Dong Wang, Hou-Feng Zheng

    Cytochrome P4501A1 (CYP1A1) enzyme is a member of the CYP superfamily of enzymes. CYP1A1 A2455G and T3801C are two most commonly studied polymorphisms loci. Previous studies have reported that CYP1A1 polymorphisms increase esophageal cancer (EC) risk. However, the results remain controversial and ambiguous. To further investigate the association between CYP1A1 polymorphisms (A2455G and T3801C) and EC risk. A meta-analysis was performed to investigate the association between CYP1A1 polymorphisms and EC risk. A total of 13 articles (A2455G and T3801C: 2 papers, A2455G: 8 papers, T3801C: 3 papers) from the PubMed containing information on the CYP1A1 polymorphisms and EC were included in this meta-analysis, with summational sample size of 1,881 EC cases and 3,786 controls. Stratified analysis was performed to evaluate the ethnicity (Caucasians and Asian) and histopathology type (esophageal squamous cell carcinoma and esophageal adenocarcinoma) effect. No obvious publication bias in the two polymorphisms was observed. Our meta-analysis revealed a significant association between the A2455G polymorphism and EC (OR = 1.55 per A allele, 95 % CI 1.29–1.85, P < 0.001). Stratification analysis by ethnicity and histopathology type showed significant association in the population of Asian origin (OR = 1.55, 95 % CI 1.28–1.89, P < 0.001) and in histopathology type of ESCC (OR = 1.40, 95 % CI 1.19–1.65, P < 0.001). We didn’t observe the significant association between CYP1A1 T3801C polymorphism and EC. We observed a difference of allele frequencies between Caucasian and Asian population in the meta-analysis. The allele frequencies in our meta-analysis were consistent with the allele frequencies in 1000 Genome Project. Our meta-analysis demonstrated distinct evidence that CYP1A1 A2455G polymorphism was associated with the risk of EC.


  • Open Access

    Meta-analysis of genome-wide studies identifies MEF2C SNPs associated with bone mineral density at forearm

    by Hou-Feng Zheng, Emma L Duncan, Laura M Yerges-Armstrong, Joel Eriksson, Ulrica Bergström, Paul J Leo, William D Leslie, David Goltzman, John Blangero, David A Hanley, et al.

    Background: Forearm fractures affect 1.7 million individuals worldwide each year and most occur earlier in life than hip fractures. While the heritability of forearm bone mineral density (BMD) and fracture is high, their genetic determinants are largely unknown. Aim: To identify genetic variants associated with forearm BMD and forearm fractures. Methods: BMD at distal radius, measured by dual-energy x-ray absorptiometry, was tested for association with common genetic variants. We conducted a meta-analysis of genome-wide association studies for BMD in 5866 subjects of European descent and then selected the variants for replication in 715 Mexican American samples. Gene-based association was carried out to supplement the single-nucleotide polymorphism (SNP) association test. We then tested the BMD-associated SNPs for association with forearm fracture in 2023 cases and 3740 controls. Results: We found that five SNPs in the introns of MEF2C were associated with forearm BMD at a genome-wide significance level (p–8) in meta-analysis (lead SNP, rs11951031[T] −0.20 SDs per allele, p=9.01×10–9). The gene-based association test suggested an association between MEF2C and forearm BMD (p=0.003). The association between MEF2C variants and risk of fracture did not achieve statistical significance (SNP rs12521522[A]: OR=1.14 (95% CI 0.92 to 1.35), p=0.14). Meta-analysis also revealed two genome-wide suggestive loci at CTNNA2 and 6q23.2. Conclusions: These findings demonstrate that variants at MEF2C were associated with forearm BMD, implicating this gene in the determination of BMD at forearm.


  • Effect of Genome-Wide Genotyping and Reference Panels on Rare Variants Imputation

    by Hou-Feng Zheng, Martin Ladouceur, Celia M.T. Greenwood, J. Brent Richards